Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Therapeutic application of dysprosium-165-FHMA in the treatment of rheumatoid knee effusions

Journal Article · · J. Nucl. Med. Technol.; (United States)
OSTI ID:5957459
Radiation synovectomy utilizing a variety of radionuclides has proven to be an effective technique in the treatment of rheumatoid arthritis. The recent introduction of the short-lived radionuclide, Dysprosium-165 (/sup 165/Dy), as a replacement for the longer-lived radiocolloids has reduced nontarget dosimetry caused by leakage of the agent from the articular cavity. A review of the methods and status of radiation synovectomy, and the application of /sup 165/Dy-ferric hydroxide macroaggregates (FHMA) as an alternative therapeutic agent is described.
Research Organization:
Brigham and Women's Hospital, Boston, MA
OSTI ID:
5957459
Journal Information:
J. Nucl. Med. Technol.; (United States), Journal Name: J. Nucl. Med. Technol.; (United States) Vol. 14:1; ISSN JNMTB
Country of Publication:
United States
Language:
English

Similar Records

Synovectomy of the rheumatoid knee using intra-articular injection of dysprosium-165-ferric hydroxide macroaggregates
Journal Article · Tue Sep 01 00:00:00 EDT 1987 · J. Bone Jt. Surg., Am. Vol.; (United States) · OSTI ID:5840582

Repeat radiation synovectomy with dysprosium 165-ferric hydroxide macroaggregates in rheumatoid knees unresponsive to initial injection
Journal Article · Wed Jun 01 00:00:00 EDT 1988 · Arthritis Rheum.; (United States) · OSTI ID:6971930

Treatment of rheumatoid synovitis of the knee with intraarticular injection of dysprosium 165-ferric hydroxide macroaggregates
Journal Article · Fri Jan 31 23:00:00 EST 1986 · Arthritis Rheum.; (United States) · OSTI ID:5737573